TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Prodia to set aside 40% of profits as dividends
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Clinical laboratory services provider Prodia Widyahusada finance director Lianda Kuswandi (left), marketing director Indriyanti Rafi Sukmawati (second left), president director Dewi Muliaty (second right), and Indopremier Securities president director Moleonoto answer journalists' questions in a press conference at Indonesia Stock Exchange (IDX) in this file photo. (JP/Anton Hermansyah)
P
ublicly listed clinical laboratory services provider PT Prodia Widyahusada announced on Monday that it would set aside 40 percent of its profits, or about Rp 60.3 billion (US$4.3 million), as dividends for its shareholders.
The company booked a profit of Rp 150.8 billion in 2017, a 71.1 percent increase compared to the previous year.
“A good performance in 2017 enabled us to set aside 40 percent of our profits in 2017 as dividends,” said Prodia president director Dewi Muliaty on Monday as reported by kompas.com.
Throughout 2017, Prodia operated 283 outlets, including 136 clinical laboratories located in 32 provinces and 118 cities across the country. The company this year is set to open more branches in Sorong in West Papua, and Bogor in West Java.
“We will carry out various initiatives and strategic decisions aimed at supporting our performance so that we can continue to be the market leader in Indonesia’s clinical lab industry,” she said.
